Clinical Researches

Terumo Blood and Cell Technologies is spearheading a pivotal clinical trial aimed at revolutionizing the management of Acute Chest Syndrome (ACS) in adults suffering...

Hologic, a leading women's health company, unveiled groundbreaking research at the 110th RSNA Scientific Assembly, showcasing the consistent performance of its Genius AI Detection...

Sobi is set to present a comprehensive range of data and analyses at the 66th Annual Meeting of the American Society of Hematology (ASH)...

H. Lundbeck A/S announced promising results from the RESOLUTION Phase IV trial, demonstrating that Vyepti (eptinezumab) significantly reduces the frequency of migraine days in...

Healthcare advancements are on the rise as the Horizonscan Geneesmiddelen from the Dutch Zorginstituut projects a significant influx of new drugs into the European...

Merck has secured the FDA’s Breakthrough Therapy designation for its investigational drug sacituzumab tirumotecan (sac-TMT). This approval targets patients battling advanced or metastatic nonsquamous...

Intra-Cellular Therapies, a biopharmaceutical leader in central nervous system disorders, has taken a significant step by submitting a supplemental New Drug Application (sNDA) to...

Jazz Pharmaceuticals is set to present significant advancements in both solid tumors and blood cancer research at the upcoming 2024 San Antonio Breast Cancer...

Novo Nordisk is set to showcase 13 new abstracts, including three oral presentations, at the 66th Annual Meeting and Exposition of the American Society...

The United Kingdom and the Republic of Korea have embarked on a collaborative journey aimed at revolutionizing clinical trials. This partnership seeks to enhance...

The Federal Joint Committee (G-BA) has embarked on a rapid report titled "Phonocardiography to rule out coronary heart disease," marking a significant step in...

A groundbreaking evaluation unveils Insulin icodec (Awiqli), a long-acting insulin poised to enhance diabetes management for adults battling Type 1 and Type 2. Approved...

Key TakeawaysDato-DXd shows promising efficacy in EGFR-mutated NSCLC, potentially offering a new treatment avenue for patients with limited options. ENHERTU demonstrates significant benefits...

Key Takeaways • TTFields therapy integrated with chemotherapy offers a new treatment avenue for pancreatic cancer. • Significant improvement in median overall survival highlights the therapy's...

Eckert & Ziegler Radiopharma GmbH has launched the production of Actinium-225, a crucial radionuclide for cancer therapies. This strategic move addresses the global shortage...